- Home
- TXG vs ATRO Comparison
TXG vs ATRO Comparison
Compare TXG & ATRO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TXG
- ATRO
- Stock Information
- Founded
- TXG 2012
- ATRO 1968
- Country
- TXG United States
- ATRO United States
- Employees
- TXG N/A
- ATRO N/A
- Industry
- TXG Biotechnology: Laboratory Analytical Instruments
- ATRO Military/Government/Technical
- Sector
- TXG Industrials
- ATRO Industrials
- Exchange
- TXG Nasdaq
- ATRO Nasdaq
- Market Cap
- TXG 1.0B
- ATRO 844.1M
- IPO Year
- TXG 2019
- ATRO N/A
- Fundamental
- Price
- TXG $9.12
- ATRO $29.57
- Analyst Decision
- TXG Buy
- ATRO Hold
- Analyst Count
- TXG 15
- ATRO 1
- Target Price
- TXG $17.65
- ATRO $21.00
- AVG Volume (30 Days)
- TXG 4.2M
- ATRO 533.9K
- Earning Date
- TXG 05-08-2025
- ATRO 05-06-2025
- Dividend Yield
- TXG N/A
- ATRO N/A
- EPS Growth
- TXG N/A
- ATRO N/A
- EPS
- TXG N/A
- ATRO N/A
- Revenue
- TXG $624,662,000.00
- ATRO $816,288,000.00
- Revenue This Year
- TXG $0.45
- ATRO $7.69
- Revenue Next Year
- TXG $9.00
- ATRO $6.12
- P/E Ratio
- TXG N/A
- ATRO N/A
- Revenue Growth
- TXG N/A
- ATRO 13.73
- 52 Week Low
- TXG $6.78
- ATRO $14.13
- 52 Week High
- TXG $28.25
- ATRO $26.63
- Technical
- Relative Strength Index (RSI)
- TXG 54.73
- ATRO 74.85
- Support Level
- TXG $7.72
- ATRO $23.25
- Resistance Level
- TXG $9.79
- ATRO $28.39
- Average True Range (ATR)
- TXG 0.54
- ATRO 1.07
- MACD
- TXG 0.21
- ATRO 0.80
- Stochastic Oscillator
- TXG 57.61
- ATRO 93.17
About TXG 10x Genomics Inc.
10x Genomics Inc is a life science technology company based in the United States. Its solutions include instruments, consumables, and software for analyzing biological systems. The company's integrated solutions include instruments, consumables, and software for analyzing biological systems at a resolution and scale that matches the complexity of biology. Its product offerings include a Chromium platform comprising microfluidic chips and related consumables, Chromium X series, Visium and Xenium platforms, and others, which are predominantly used for the study of biological components. Geographically, the company derives maximum revenue from the United States and the rest from Americas (excluding the United States), Europe, Middle East and Africa, China, and Asia-Pacific (excluding China).
About ATRO Astronics Corporation
Astronics Corp supplies products to the aerospace, defense, and electronics industries. The company has two reportable segments namely Aerospace and Test Systems. The aerospace segment serves three primary markets: military, commercial transport, and General Aviation. The Test Systems segment serves the aerospace, defense, and semiconductor markets. The company generates a majority of its revenue from the Aerospace segment. Geographically, it generates a majority of its revenue from the United States.